Celularity Inc
NASDAQ:CELU

Watchlist Manager
Celularity Inc Logo
Celularity Inc
NASDAQ:CELU
Watchlist
Price: 1.29 USD -2.27%
Market Cap: 36.5m USD

Wall Street
Price Targets

CELU Price Targets Summary
Celularity Inc

Wall Street analysts forecast CELU stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CELU is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

Lowest
Price Target
6.06 USD
370% Upside
Average
Price Target
6.12 USD
374% Upside
Highest
Price Target
6.3 USD
388% Upside
Celularity Inc Competitors:
Price Targets
ABBV
Abbvie Inc
9% Upside
6160
Beigene Ltd
36% Upside
MDGL
Madrigal Pharmaceuticals Inc
0% Upside
KMDA
Kamada Ltd
87% Upside
SBTX
SkinBioTherapeutics PLC
117% Upside
NRIX
Nurix Therapeutics Inc
47% Upside
IMMU
Mendus AB (publ)
227% Upside
ALXO
ALX Oncology Holdings Inc
119% Upside

Revenue
Forecast

Revenue Estimate
Celularity Inc

The compound annual growth rate of Celularity Inc's revenue for the next 2 years is -9%.

N/A
Past Growth
-9%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Celularity Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss

Net Income
Forecast

Net Income Estimate
Celularity Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CELU's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for CELU is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is Celularity Inc's Revenue forecast?
Projected CAGR
-9%

The compound annual growth rate of Celularity Inc's revenue for the next 2 years is -9%.

Back to Top